November 5, 2021
A large, multi-site study funded by the National Institutes of Health aims to test the effectiveness of three existing drugs, including controversial ivermectin, to treat the symptoms of COVID-19. Known as ACTIV-6, the study is now underway at UT Health San Antonio.
November 4, 2021
A recent study validates use of a brief questionnaire to screen patients for chemical intolerance, after a large national sampling, and the researchers conclude the condition likely affects one in five people.
October 29, 2021
Researchers at The University of Texas Health Science Center at San Antonio, who see patients at University Health, are recruiting 900 adult COVID-19 survivors for a federally funded study that seeks to understand why some people have prolonged symptoms or develop new or returning symptoms after the acute phase of SARS-CoV-2 infection. The partnership also includes the Laredo Health Department as a clinical partner in this major effort.
UT Health Science Center San Antonio among group tapped by NIH to map senescent ‘zombie’ cells in the body
October 29, 2021
Researchers nationwide, including a team from The University of Texas Health Science Center at San Antonio, are embarking on a massive effort to learn the locations and roles of senescent “zombie” cells in humans.
October 26, 2021
Lindsay Fry is a breast cancer survivor who was first diagnosed in 2019. Her treatment regimen of surgery, radiation and chemotherapy began in fall 2019. Shortly after completing her treatment, Fry became the first participant in a new clinical trial at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) that aims to help breast cancer survivors regain their energy and remain cancer free.
October 22, 2021
What if a daily or weekly blood sample could monitor each patient’s risk of metastasis, indicating the need for aggressive therapy before cancer spread is established? That’s the ultimate goal of studies published by researchers from The University of Texas Health Science Center at San Antonio.